(a)
(b)
(c)
(d)
(e)
(f)
Figure 4: Effect of YSSXG on biomarkers of pro- and antioxidative system with thalassemia disease (). (a) The SOD activity level of RBC. (b) The SOD activity level of serum. (c) The GSH-Px activity level of RBC. (d) The GSH-Px activity level of serum. (e) The MDA activity level of RBC. (f) The MDA activity level of serum. , , compared with pretreatment.